Connor, Clark & Lunn Investment Management (CC&L)’s Solid Biosciences SLDB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-721
| Closed | -$5K | – | 1409 |
|
|
2022
Q3 | $5K | Buy |
+721
| New | +$5K | ﹤0.01% | 1083 |
|
|
2022
Q2 | – | Sell |
-1,400
| Closed | -$25K | – | 1190 |
|
|
2022
Q1 | $25K | Sell |
1,400
-7,952
| -85% | -$142K | ﹤0.01% | 1009 |
|
|
2021
Q4 | $245K | Buy |
9,352
+3,498
| +60% | +$91.6K | ﹤0.01% | 931 |
|
|
2021
Q3 | $210K | Buy |
5,854
+3,714
| +174% | +$133K | ﹤0.01% | 938 |
|
|
2021
Q2 | $118K | Sell |
2,140
-3,555
| -62% | -$196K | ﹤0.01% | 936 |
|
|
2021
Q1 | $472K | Buy |
+5,695
| New | +$472K | ﹤0.01% | 798 |
|